dc.contributor.author | Solberg, Runar Barstad | |
dc.contributor.author | Fretheim, Atle | |
dc.contributor.author | Elgersma, Ingeborg Hess | |
dc.contributor.author | Fagernes, Mette | |
dc.contributor.author | Iversen, Bjørn Gunnar | |
dc.contributor.author | Hemkens, Lars G. | |
dc.contributor.author | Rose, Christopher James | |
dc.contributor.author | Elstrøm, Petter | |
dc.date.accessioned | 2024-10-30T08:47:29Z | |
dc.date.available | 2024-10-30T08:47:29Z | |
dc.date.created | 2024-08-05T15:58:41Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | The BMJ. 2024, 386 . | en_US |
dc.identifier.issn | 1756-1833 | |
dc.identifier.uri | https://hdl.handle.net/11250/3161497 | |
dc.description.abstract | Objective: To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period.
Design: Pragmatic randomised superiority trial.
Setting: Norway.
Participants: 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm.
Interventions: Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14 day period (mask wearing at home or work was not mentioned). Participants in the control arm were assigned to not wear a surgical face mask in public places.
Main outcome measures: The primary outcome was self-reported respiratory symptoms consistent with a respiratory infection. Secondary outcomes included self-reported and registered covid-19 infection and self-reported sick leave.
Results: Between 10 February 2023 and 27 April 2023, 4647 participants were randomised of whom 4575 (2788 women (60.9%); mean age 51.0 (standard deviation 15.0) years) were included in the intention-to-treat analysis: 2313 (50.6%) in the intervention arm and 2262 (49.4%) in the control arm. 163 events (8.9%) of self-reported symptoms consistent with respiratory infection were reported in the intervention arm and 239 (12.2%) in the control arm. The marginal odds ratio was 0.71 (95% confidence interval (CI) 0.58 to 0.87; P=0.001) favouring the face mask intervention. The absolute risk difference was −3.2% (95% CI −5.2% to −1.3%; P<0.001). No statistically significant effect was found on self- reported (marginal odds ratio 1.07, 95% CI 0.58 to 1.98; P=0.82) or registered covid-19 infection (effect estimate and 95% CI not estimable owing to lack of events in the intervention arm). Self-reported sick leave was equally distributed between the intervention and control groups (marginal odds ratio 1.00, 0.81 to 1.22; P=0.97).
Conclusion: Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.relation.ispartofseries | The BMJ; | |
dc.rights | Navngivelse-Ikkekommersiell 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/deed.no | * |
dc.title | Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |
dc.identifier.doi | http://dx.doi.org/10.1136/bmj-2023-078918 | |
dc.identifier.cristin | 2284515 | |
dc.source.journal | The BMJ | en_US |
dc.source.volume | 386 | en_US |
dc.source.pagenumber | 9 | en_US |